Concentra Group Holdings Parent, Inc. (CON) Balance Sheet

The balance sheet is expanding rapidly, driven by acquisitions and organic growth, but the funding mix has shifted heavily toward debt. Equity growth lags asset growth, indicating that leverage is financing the expansion. This suggests a deliberate strategy to scale quickly, though it increases financial risk if cash flows falter.

The dramatic increase in leverage appears tied to the separation from Select Medical and subsequent acquisitions, including the $333M outflow noted in Q4 2025. While the low absolute debt level relative to assets (70% of assets) is manageable, the high D/E ratio signals a thin equity cushion. Investors should monitor whether operating cash flow can service this debt, especially given the CEO transition.

The asset mix is heavily weighted toward goodwill from acquisitions, indicating that growth has been inorganic. This raises impairment risk if expected synergies fail to materialize. PPE growth of 29% over the period suggests ongoing investment in clinic infrastructure, but the modest size relative to goodwill implies the business is more service-oriented than asset-heavy.

The equity base was significantly reduced by a special dividend, but retained earnings have been rebuilding steadily, rising from $13.6M in Q4 2024 to $244M by Q2 2026. This indicates strong profitability is being retained to bolster equity. However, the low absolute equity level relative to debt leaves limited buffer for unexpected losses.

Liquidity has improved, with cash more than doubling year-over-year, providing a stronger buffer against short-term obligations. The current ratio above 1 indicates adequate coverage of current liabilities. However, the cash balance remains modest relative to total debt, so the company relies on operating cash flow to service debt, which has been robust but volatile.